Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan 28;13(4):515-24.
doi: 10.3748/wjg.v13.i4.524.

Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy

Affiliations

Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy

Lukasz Liszka et al. World J Gastroenterol. .

Abstract

Aim: To assess the usefulness of two independent histopathological classifications of rectal cancer regression following neo-adjuvant therapy.

Methods: Forty patients at the initial stage cT3NxM0 submitted to preoperative radiotherapy (42 Gy during 18 d) and then to radical surgical treatment. The relationship between "T-downstaging" versus regressive changes expressed by tumor regression grade (TRG 1-5) and Nasierowska-Guttmejer classification (NG 1-3) was studied as well as the relationship between TRG and NG versus local tumor stage ypT and lymph nodes status, ypN.

Results: Complete regression (ypT0, TRG 1) was found in one patient. "T-downstaging" was observed in 11 (27.5%) patients. There was a weak statistical significance of the relationship between "T-downstaging" and TRG staging and NG stage. Patients with ypT1 were diagnosed as TRG 2-3 while those with ypT3 as TRG5. No lymph node metastases were found in patients with TRG 1-2. None of the patients without lymph node metastases were diagnosed as TRG 5. Patients in the ypT1 stage were NG 1-2. No lymph node metastases were found in NG 1. There was a significant correlation between TRG and NG.

Conclusion: Histopathological classifications may be useful in the monitoring of the effects of hyperfractionated preoperative radiotherapy in patients with rectal cancer at the stage of cT3NxM0. There is no unequivocal relationship between "T-downstaging" and TRG and NG. There is some concordance in the assessment of lymph node status with ypT, TRG and NG. TRG and NG are of limited value for the risk assessment of the lymph node involvement.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acellular mucin pools in the intestinal wall (HE x 200).
Figure 2
Figure 2
Complete tumor regression following radiotherapy. Inflammatory infiltrations, mucin pool and focal fibrosis in the stroma (HE x 64).
Figure 3
Figure 3
Degeneration and necrosis of tumor cells following radiotherapy (HE x 250).
Figure 4
Figure 4
Degenerated adenocarcinoma cells following radiotherapy (HE x 125).
Figure 5
Figure 5
Dispersed degenerated adenocarcinoma cells following radiotherapy (HE x 125).
Figure 6
Figure 6
Dispersed degenerated adenocarcinoma cells following radiotherapy (HE x 125).

References

    1. National Comprehensive Cancer Network. Rectal Cancer. Clinical Practice Guidelines in Oncology. Version 2.2006; cited 2006-04-24. Available from: http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf.
    1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
    1. Church JM, Gibbs P, Chao MW, Tjandra JJ. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum. 2003;46:389–402. - PubMed
    1. Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, Orsay C, Church J, Otchy D, Cohen J, et al. Practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 2005;48:411–423. - PubMed
    1. Nasierowska-Guttmejer A. Histopathological and immunohistochemical markers in rectal cancer after preoperative radiochemotherapy. J Oncol. 2001;51 Suppl 3:1–57 (in Polish, with English abstract).